Australia markets closed

Elis SA (ELSSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
21.700.00 (0.00%)
As of 03:44PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close21.70
Open21.70
Bid0.00 x 0
Ask0.00 x 0
Day's range21.70 - 21.70
52-week range15.50 - 23.50
Volume1,400
Avg. volume445
Market cap5.181B
Beta (5Y monthly)1.86
PE ratio (TTM)18.87
EPS (TTM)1.15
Earnings dateN/A
Forward dividend & yield0.45 (2.08%)
Ex-dividend date30 May 2023
1y target estN/A
  • GlobeNewswire

    Elis: Disclosure of the number of shares forming the capital and of the number of voting rights as of 29 02 2024

    DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTE AU 29 FEVRIER 2024 Article L. 233-8-II du Code de CommerceArticle 223-16 du Règlement général de l’AMF Nombre d’actions composant le capital social 234 000 047 Nombre de droits de vote théoriques 265 300 252 Nombre de droits de vote exerçables 265 217 860 Cette déclaration est en ligne sur le site internet d’Elis www.elis.com DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITALAND OF THE TOTAL NUMBER OF VO

  • GlobeNewswire

    Elis: €400 million note issuance

    Elis successfully priced a €400 million note issuance under its EMTN Programme Saint-Cloud, March 14, 2024 – Elis announces today that it has successfully priced the issue of €400 million aggregate principal amount of senior unsecured notes under its EMTN (Euro Medium Term Notes) Programme. The maturity of the notes is 6 years and the notes carry a fixed annual coupon of 3.75%. The very positive response given to this issue, with a final orderbook above €2.8 billion, which represents a subscript

  • GlobeNewswire

    Elis: Full-year 2023 results

    Elis delivers a record financial performance in 2023 Numerous industrial and commercial successes Acceleration of Group deleveraging Elis’ 2023 operational and financial performance confirms the relevance of the Group’s strategy and its business model Revenue of €4,309.4m (+12.8%, of which +11.8% organic)Adjusted EBITDA up +17.1% to €1,474.8m (margin up +130bps at 34.2%)Adjusted EBIT up +25.6% to €683.1m (margin up +160bps at 15.9%) Headline net income per share up +22.4% to €1.86 (+18.4% at €1.